HGNC Family | Phosphodiesterases (PDE) |
Name | phosphodiesterase 4A, cAMP-specific |
Description | The protein encoded by this gene belongs to the cyclic nucleotide phosphodiesterase (PDE) family, and PDE4 subfamily. This PDE hydrolyzes the second messenger, cAMP, which is a regulator and mediator of a number of cellular responses to extracellular signals. Thus, by regulating the cellular concentration of cAMP, this protein plays a key role in many important physiological processes. Alternatively spliced transcript variants encoding different isoforms have been described for this gene.[provided by RefSeq, Jul 2011] |
Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nPhosphodiesterase‐4A (PDE4A) isoforms are critical regulators of intracellular cyclic AMP (cAMP) signaling through their ability to catalyze cAMP degradation in a spatially and temporally controlled manner. Different splice variants—including long forms such as PDE4A1, PDE4A4, PDE4A5, PDE4A8, PDE4A10, and PDE4A11—exhibit unique N‐terminal domains that dictate subcellular targeting, membrane association, and interaction with discrete signaling complexes. For example, a short helical motif in PDE4A1 governs its selective membrane binding via a phosphatidic acid–selective module, while alternative N‐terminal sequences in PDE4A10 and PDE4A11 confer distinct catalytic properties, subcellular localization, and sensitivities to protein kinase A activation and inhibitors. These studies underscore that isoform diversity within PDE4A is central to shaping compartmentalized cAMP dynamics in diverse tissues."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "11"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its intrinsic catalytic role, PDE4A interacts with several regulatory and scaffolding proteins that modulate its activity and thereby impact diverse cell functions. Specific interactions—with proteins such as the immunophilin XAP2 (via PDE4A5), the risk factor DISC1 in the cerebellum, and the p75 neurotrophin receptor in tissue remodeling—demonstrate that PDE4A not only governs local cAMP concentrations but also influences cellular processes including T‐cell activation, epithelial‐mesenchymal transition in lung epithelial cells, and excitation–contraction coupling in cardiomyocytes. Moreover, PDE4A expression is dynamically regulated in response to stimuli in inflammatory and vascular cells, and its modulation by selective inhibitors (for example, rolipram and GSK256066) further reveals a key role in controlling receptor‐mediated responses, cell proliferation, angiogenesis, and even immune cell adhesion."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "12", "end_ref": "24"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nClinically, dysregulation of PDE4A function is implicated in a range of pathological conditions. Aberrant expression and altered protein–protein interactions of PDE4A isoforms have been linked to oncogenesis in brain tumors and pituitary adenomas, contribute to immune cell function in chronic lymphocytic leukemia and sepsis, and modulate neuronal survival in experimental models of Parkinson’s disease. In addition, PDE4A disturbances influence autophagy‐dependent epithelial–mesenchymal transition in hepatocarcinoma cells and support the control of atrial cAMP signals in arrhythmia. The therapeutic targeting of PDE4A—by agents such as roflumilast, apremilast, and novel compounds like FCPR16—thus holds promise for treating a diverse set of diseases including inflammatory disorders, neurodegenerative conditions, and cancer."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "25", "end_ref": "36"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "G Rena, F Begg, A Ross, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Molecular cloning, genomic positioning, promoter identification, and characterization of the novel cyclic amp-specific phosphodiesterase PDE4A10."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Pharmacol (2001)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/mol.59.5.996"}], "href": "https://doi.org/10.1124/mol.59.5.996"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11306681"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11306681"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "P I Lario, B Bobechko, K Bateman, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Purification and characterization of the human PDE4A catalytic domain (PDE4A330-723) expressed in Sf9 cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arch Biochem Biophys (2001)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1006/abbi.2001.2513"}], "href": "https://doi.org/10.1006/abbi.2001.2513"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11566027"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11566027"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Eunyi Moon, Richard Lee, Richard Near, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2002)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11839681"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11839681"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "George S Baillie, Elaine Huston, Grant Scotland, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TAPAS-1, a novel microdomain within the unique N-terminal region of the PDE4A1 cAMP-specific phosphodiesterase that allows rapid, Ca2+-triggered membrane association with selectivity for interaction with phosphatidic acid."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M108353200"}], "href": "https://doi.org/10.1074/jbc.M108353200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11994273"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11994273"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Graeme B Bolger, Alexander H Peden, Michael R Steele, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Attenuation of the activity of the cAMP-specific phosphodiesterase PDE4A5 by interaction with the immunophilin XAP2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M303269200"}], "href": "https://doi.org/10.1074/jbc.M303269200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12810716"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12810716"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Rachael Barber, George S Baillie, Reinhard Bergmann, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential expression of PDE4 cAMP phosphodiesterase isoforms in inflammatory cells of smokers with COPD, smokers without COPD, and nonsmokers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Lung Cell Mol Physiol (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajplung.00384.2003"}], "href": "https://doi.org/10.1152/ajplung.00384.2003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15047569"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15047569"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Derek A Wallace, Lee Ann Johnston, Elaine Huston, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification and characterization of PDE4A11, a novel, widely expressed long isoform encoded by the human PDE4A cAMP phosphodiesterase gene."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Pharmacol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/mol.104.009423"}], "href": "https://doi.org/10.1124/mol.104.009423"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15738310"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15738310"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Miles D Houslay, Peter Schafer, Kam Y J Zhang "}, {"type": "b", "children": [{"type": "t", "text": "Keynote review: phosphodiesterase-4 as a therapeutic target."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Drug Discov Today (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/S1359-6446(05)03622-6"}], "href": "https://doi.org/10.1016/S1359-6446(05"}, {"type": "t", "text": "03622-6) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16257373"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16257373"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Kam Y J Zhang, Prabha N Ibrahim, Sam Gillette, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Phosphodiesterase-4 as a potential drug target."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Expert Opin Ther Targets (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1517/14728222.9.6.1283"}], "href": "https://doi.org/10.1517/14728222.9.6.1283"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16300476"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16300476"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "E Huston, T M Houslay, G S Baillie, et al. "}, {"type": "b", "children": [{"type": "t", "text": "cAMP phosphodiesterase-4A1 (PDE4A1) has provided the paradigm for the intracellular targeting of phosphodiesterases, a process that underpins compartmentalized cAMP signalling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Soc Trans (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BST0340504"}], "href": "https://doi.org/10.1042/BST0340504"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16856845"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16856845"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Elaine Huston, Irene Gall, Thomas M Houslay, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Helix-1 of the cAMP-specific phosphodiesterase PDE4A1 regulates its phospholipase-D-dependent redistribution in response to release of Ca2+."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Sci (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1242/jcs.03106"}], "href": "https://doi.org/10.1242/jcs.03106"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16940352"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16940352"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Benjamin D Sachs, George S Baillie, Julianne R McCall, et al. "}, {"type": "b", "children": [{"type": "t", "text": "p75 neurotrophin receptor regulates tissue fibrosis through inhibition of plasminogen activation via a PDE4/cAMP/PKA pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1083/jcb.200701040"}], "href": "https://doi.org/10.1083/jcb.200701040"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17576803"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17576803"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "S Hossein Fatemi, Teri J Reutiman, Timothy D Folsom, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Phosphodiesterase-4A expression is reduced in cerebella of patients with bipolar disorder."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Psychiatr Genet (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/YPG.0b013e3283060fb8"}], "href": "https://doi.org/10.1097/YPG.0b013e3283060fb8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19018233"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19018233"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Patricia Goldhoff, Nicole M Warrington, David D Limbrick, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Targeted inhibition of cyclic AMP phosphodiesterase-4 promotes brain tumor regression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-08-0827"}], "href": "https://doi.org/10.1158/1078-0432.CCR-08-0827"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19047098"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19047098"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Anna Laura Schmidt, Caroline Brunetto de Farias, Ana Lucia Abujamra, et al. "}, {"type": "b", "children": [{"type": "t", "text": "BDNF and PDE4, but not the GRPR, regulate viability of human medulloblastoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Neurosci (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12031-009-9221-8"}], "href": "https://doi.org/10.1007/s12031-009-9221-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19642024"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19642024"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Jens Selige, Hermann Tenor, Armin Hatzelmann, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cytokine-dependent balance of mitogenic effects in primary human lung fibroblasts related to cyclic AMP signaling and phosphodiesterase 4 inhibition."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.22037"}], "href": "https://doi.org/10.1002/jcp.22037"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20082309"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20082309"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Elisa Bjørgo, Silje A Solheim, Hilde Abrahamsen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cross talk between phosphatidylinositol 3-kinase and cyclic AMP (cAMP)-protein kinase a signaling pathways at the level of a protein kinase B/beta-arrestin/cAMP phosphodiesterase 4 complex."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.00696-09"}], "href": "https://doi.org/10.1128/MCB.00696-09"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20086095"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20086095"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Dave Singh, Frank Petavy, Alex J Macdonald, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The inhaled phosphodiesterase 4 inhibitor GSK256066 reduces allergen challenge responses in asthma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Respir Res (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1465-9921-11-26"}], "href": "https://doi.org/10.1186/1465-9921-11-26"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20193079"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20193079"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Andrés Norambuena, Claudia Metz, Juan E Jung, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Phosphatidic acid induces ligand-independent epidermal growth factor receptor endocytic traffic through PDE4 activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Biol Cell (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1091/mbc.E10-02-0167"}], "href": "https://doi.org/10.1091/mbc.E10-02-0167"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20554760"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20554760"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Wito Richter, Moses Xie, Colleen Scheitrum, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Conserved expression and functions of PDE4 in rodent and human heart."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Basic Res Cardiol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00395-010-0138-8"}], "href": "https://doi.org/10.1007/s00395-010-0138-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21161247"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21161247"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Saima Muzaffar, Jamie Y Jeremy, Gianni D Angelini, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NADPH oxidase 4 mediates upregulation of type 4 phosphodiesterases in human endothelial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.22922"}], "href": "https://doi.org/10.1002/jcp.22922"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21732365"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21732365"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Alessandra Ghigo, Alessia Perino, Hind Mehel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Phosphoinositide 3-kinase γ protects against catecholamine-induced ventricular arrhythmia through protein kinase A-mediated regulation of distinct phosphodiesterases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circulation (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/CIRCULATIONAHA.112.114074"}], "href": "https://doi.org/10.1161/CIRCULATIONAHA.112.114074"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23008439"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23008439"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Vicky Chaar, Sandrine Laurance, Claudine Lapoumeroulie, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hydroxycarbamide decreases sickle reticulocyte adhesion to resting endothelium by inhibiting endothelial lutheran/basal cell adhesion molecule (Lu/BCAM) through phosphodiesterase 4A activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M113.506121"}], "href": "https://doi.org/10.1074/jbc.M113.506121"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24616094"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24616094"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Abdurazzag Abusnina, Thérèse Keravis, Qingwei Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tumour growth inhibition and anti-angiogenic effects using curcumin correspond to combined PDE2 and PDE4 inhibition."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Thromb Haemost (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1160/TH14-05-0454"}], "href": "https://doi.org/10.1160/TH14-05-0454"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25230992"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25230992"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Kevin Kelly, Alex Mejia, Avvaru N Suhasini, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Safety and Pharmacodynamics of the PDE4 Inhibitor Roflumilast in Advanced B-cell Malignancies."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-16-1207"}], "href": "https://doi.org/10.1158/1078-0432.CCR-16-1207"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27542768"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27542768"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Kirsty F Houslay, Frank Christian, Ruth MacLeod, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of a multifunctional docking site on the catalytic unit of phosphodiesterase-4 (PDE4) that is utilised by multiple interaction partners."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem J (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BCJ20160849"}], "href": "https://doi.org/10.1042/BCJ20160849"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27993970"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27993970"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Christophe Lelubre, Hayfa Medfai, Israa Akl, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Leukocyte phosphodiesterase expression after lipopolysaccharide and during sepsis and its relationship with HLA-DR expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Leukoc Biol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1189/jlb.5A0516-240R"}], "href": "https://doi.org/10.1189/jlb.5A0516-240R"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28356347"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28356347"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Flavia Niccolini, Heather Wilson, Gennaro Pagano, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss of phosphodiesterase 4 in Parkinson disease: Relevance to cognitive deficits."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurology (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1212/WNL.0000000000004201"}], "href": "https://doi.org/10.1212/WNL.0000000000004201"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28701494"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28701494"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Nicholas C Vierra, Prasanna K Dadi, Sarah C Milian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TALK-1 channels control β cell endoplasmic reticulum Ca"}, {"type": "a", "children": [{"type": "t", "text": "sup"}], "href": "sup"}, {"type": "t", "text": "2+"}, {"type": "a", "children": [{"type": "t", "text": "/sup"}], "href": "/sup"}, {"type": "t", "text": " homeostasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Signal (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/scisignal.aan2883"}], "href": "https://doi.org/10.1126/scisignal.aan2883"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28928238"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28928238"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Nicholas C Vierra, Matthew T Dickerson, Kelli L Jordan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TALK-1 reduces delta-cell endoplasmic reticulum and cytoplasmic calcium levels limiting somatostatin secretion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Metab (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molmet.2018.01.016"}], "href": "https://doi.org/10.1016/j.molmet.2018.01.016"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29402588"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29402588"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Jiahong Zhong, Hui Yu, Chang Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of phosphodiesterase 4 by FCPR16 protects SH-SY5Y cells against MPP"}, {"type": "a", "children": [{"type": "t", "text": "sup"}], "href": "sup"}, {"type": "t", "text": "+"}, {"type": "a", "children": [{"type": "t", "text": "/sup"}], "href": "/sup"}, {"type": "t", "text": "-induced decline of mitochondrial membrane potential and oxidative stress."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Redox Biol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.redox.2018.02.008"}], "href": "https://doi.org/10.1016/j.redox.2018.02.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29475134"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29475134"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Mariana Ferreira Bizzi, Sergio Veloso Brant Pinheiro, Graeme B Bolger, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reduced protein expression of the phosphodiesterases PDE4A4 and PDE4A8 in AIP mutation positive somatotroph adenomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Endocrinol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.mce.2018.04.014"}], "href": "https://doi.org/10.1016/j.mce.2018.04.014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29729370"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29729370"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Shaobo Hu, Liyu Wang, Xi Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Autophagy induces transforming growth factor-β-dependent epithelial-mesenchymal transition in hepatocarcinoma cells through cAMP response element binding signalling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.13825"}], "href": "https://doi.org/10.1111/jcmm.13825"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30134011"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30134011"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Jiahong Zhong, Jinfeng Xie, Jiao Xiao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of PDE4 by FCPR16 induces AMPK-dependent autophagy and confers neuroprotection in SH-SY5Y cells and neurons exposed to MPP"}, {"type": "a", "children": [{"type": "t", "text": "sup"}], "href": "sup"}, {"type": "t", "text": "+"}, {"type": "a", "children": [{"type": "t", "text": "/sup"}], "href": "/sup"}, {"type": "t", "text": "-induced oxidative insult."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Free Radic Biol Med (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.freeradbiomed.2019.02.027"}], "href": "https://doi.org/10.1016/j.freeradbiomed.2019.02.027"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30818055"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30818055"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Bernardo Dolce, Torsten Christ, Nefeli Grammatika Pavlidou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Impact of phosphodiesterases PDE3 and PDE4 on 5-hydroxytryptamine receptor4-mediated increase of cAMP in human atrial fibrillation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Naunyn Schmiedebergs Arch Pharmacol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00210-020-01968-1"}], "href": "https://doi.org/10.1007/s00210-020-01968-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32949251"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32949251"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Alexandre Le Joncour, Paul Régnier, Anna Maciejewski-Duval, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reduction of Neutrophil Activation by Phosphodiesterase 4 Blockade in Behçet's Disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arthritis Rheumatol (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/art.42486"}], "href": "https://doi.org/10.1002/art.42486"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36862398"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36862398"}]}]}]}
|
Synonyms | DPDE2, PDE4, PDE46 |
Proteins | PDE4A_HUMAN |
NCBI Gene ID | 5141 |
API | |
Download Associations | |
Predicted Functions |
![]() |
Co-expressed Genes |
![]() |
Expression in Tissues and Cell Lines |
![]() |
PDE4A has 8,578 functional associations with biological entities spanning 8 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 117 datasets.
Click the + buttons to view associations for PDE4A from the datasets below.
If available, associations are ranked by standardized value
Dataset | Summary | |
---|---|---|
Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of PDE4A gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of PDE4A gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of PDE4A gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of PDE4A gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of PDE4A gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of PDE4A gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PDE4A gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PDE4A gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of PDE4A gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of PDE4A gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
CellMarker Gene-Cell Type Associations | cell types associated with PDE4A gene from the CellMarker Gene-Cell Type Associations dataset. | |
ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of PDE4A gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
ChEA Transcription Factor Targets | transcription factors binding the promoter of PDE4A gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of PDE4A gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PDE4A gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing PDE4A protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing PDE4A protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with PDE4A protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with PDE4A protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of PDE4A gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
COSMIC Cell Line Gene Mutation Profiles | cell lines with PDE4A gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
CTD Gene-Chemical Interactions | chemicals interacting with PDE4A gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
CTD Gene-Disease Associations | diseases associated with PDE4A gene/protein from the curated CTD Gene-Disease Associations dataset. | |
dbGAP Gene-Trait Associations | traits associated with PDE4A gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset. | |
DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of PDE4A protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
DepMap CRISPR Gene Dependency | cell lines with fitness changed by PDE4A gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with PDE4A gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with PDE4A gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with PDE4A gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
DisGeNET Gene-Disease Associations | diseases associated with PDE4A gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
DisGeNET Gene-Phenotype Associations | phenotypes associated with PDE4A gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
DrugBank Drug Targets | interacting drugs for PDE4A protein from the curated DrugBank Drug Targets dataset. | |
ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at PDE4A gene from the ENCODE Histone Modification Site Profiles dataset. | |
ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of PDE4A gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
ENCODE Transcription Factor Targets | transcription factors binding the promoter of PDE4A gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing PDE4A from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
GAD Gene-Disease Associations | diseases associated with PDE4A gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
GAD High Level Gene-Disease Associations | diseases associated with PDE4A gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of PDE4A gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
GeneRIF Biological Term Annotations | biological terms co-occuring with PDE4A gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing PDE4A from the GeneSigDB Published Gene Signatures dataset. | |
GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of PDE4A gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of PDE4A gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of PDE4A gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PDE4A gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of PDE4A gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of PDE4A gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
GO Biological Process Annotations 2015 | biological processes involving PDE4A gene from the curated GO Biological Process Annotations 2015 dataset. | |
GO Biological Process Annotations 2025 | biological processes involving PDE4A gene from the curated GO Biological Process Annotations2025 dataset. | |
GO Cellular Component Annotations 2015 | cellular components containing PDE4A protein from the curated GO Cellular Component Annotations 2015 dataset. | |
GO Cellular Component Annotations 2023 | cellular components containing PDE4A protein from the curated GO Cellular Component Annotations 2023 dataset. | |
GO Molecular Function Annotations 2015 | molecular functions performed by PDE4A gene from the curated GO Molecular Function Annotations 2015 dataset. | |
GO Molecular Function Annotations 2023 | molecular functions performed by PDE4A gene from the curated GO Molecular Function Annotations 2023 dataset. | |
GO Molecular Function Annotations 2025 | molecular functions performed by PDE4A gene from the curated GO Molecular Function Annotations 2025 dataset. | |
GTEx Tissue Gene Expression Profiles | tissues with high or low expression of PDE4A gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of PDE4A gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PDE4A gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of PDE4A gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
Guide to Pharmacology Chemical Ligands of Receptors | ligands (chemical) binding PDE4A receptor from the curated Guide to Pharmacology Chemical Ligands of Receptors dataset. | |
GWASdb SNP-Disease Associations | diseases associated with PDE4A gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
GWASdb SNP-Phenotype Associations | phenotypes associated with PDE4A gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of PDE4A gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
HMDB Metabolites of Enzymes | interacting metabolites for PDE4A protein from the curated HMDB Metabolites of Enzymes dataset. | |
HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of PDE4A gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
HPA Tissue Gene Expression Profiles | tissues with high or low expression of PDE4A gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PDE4A gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
Hub Proteins Protein-Protein Interactions | interacting hub proteins for PDE4A from the curated Hub Proteins Protein-Protein Interactions dataset. | |
HuGE Navigator Gene-Phenotype Associations | phenotypes associated with PDE4A gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
InterPro Predicted Protein Domain Annotations | protein domains predicted for PDE4A protein from the InterPro Predicted Protein Domain Annotations dataset. | |
JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of PDE4A gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
KEA Substrates of Kinases | kinases that phosphorylate PDE4A protein from the curated KEA Substrates of Kinases dataset. | |
KEGG Pathways | pathways involving PDE4A protein from the KEGG Pathways dataset. | |
Kinase Library Serine Threonine Kinome Atlas | kinases that phosphorylate PDE4A protein from the Kinase Library Serine Threonine Atlas dataset. | |
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of PDE4A gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of PDE4A gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with PDE4A gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of PDE4A gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of PDE4A gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of PDE4A gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PDE4A gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
LOCATE Curated Protein Localization Annotations | cellular components containing PDE4A protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain PDE4A protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
MiRTarBase microRNA Targets | microRNAs targeting PDE4A gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of PDE4A gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of PDE4A gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
MSigDB Cancer Gene Co-expression Modules | co-expressed genes for PDE4A from the MSigDB Cancer Gene Co-expression Modules dataset. | |
MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of PDE4A gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of PDE4A gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
Pathway Commons Protein-Protein Interactions | interacting proteins for PDE4A from the Pathway Commons Protein-Protein Interactions dataset. | |
PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of PDE4A gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of PDE4A gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
PFOCR Pathway Figure Associations 2023 | pathways involving PDE4A protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
PFOCR Pathway Figure Associations 2024 | pathways involving PDE4A protein from the Wikipathways PFOCR 2024 dataset. | |
Phosphosite Textmining Biological Term Annotations | biological terms co-occuring with PDE4A protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset. | |
PhosphoSitePlus Substrates of Kinases | kinases that phosphorylate PDE4A protein from the curated PhosphoSitePlus Substrates of Kinases dataset. | |
Reactome Pathways 2014 | pathways involving PDE4A protein from the Reactome Pathways dataset. | |
Reactome Pathways 2024 | pathways involving PDE4A protein from the Reactome Pathways 2024 dataset. | |
Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of PDE4A gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of PDE4A gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of PDE4A gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PDE4A gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at PDE4A gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of PDE4A gene from the RummaGEO Drug Perturbation Signatures dataset. | |
RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of PDE4A gene from the RummaGEO Gene Perturbation Signatures dataset. | |
SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Protein Ligands | ligand (protein) perturbations changing phosphorylation of PDE4A protein from the SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Protein Ligands dataset. | |
SynGO Synaptic Gene Annotations | synaptic terms associated with PDE4A gene from the SynGO Synaptic Gene Annotations dataset. | |
TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of PDE4A gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of PDE4A gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of PDE4A gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of PDE4A protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of PDE4A protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of PDE4A protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of PDE4A protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with PDE4A protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with PDE4A protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
WikiPathways Pathways 2014 | pathways involving PDE4A protein from the Wikipathways Pathways 2014 dataset. | |
WikiPathways Pathways 2024 | pathways involving PDE4A protein from the WikiPathways Pathways 2024 dataset. | |